Qiagen NV

NYSE:QGEN   3:59:53 PM EDT
+0.42 (+0.96%)
Products, Strategic Combinations, Regulatory

Neuron23 And Qiagen Announce Collaboration To Develop The First Next-Generation Sequencing Companion Diagnostic For Novel Parkinson's Disease Drug

Published: 09/14/2022 20:19 GMT
Qiagen NV (QGEN) - Neuron23 and Qiagen Announce Collaboration to Develop the First Next-generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug.
Qiagen NV - Under Collaboration, Co to Develop and Validate a Clinical Trial Assay That Will Detect a Combination of Biomarkers Discovered by Neuron23.
Qiagen NV - Financial Terms of Agreement Were Not Disclosed.